Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system

Journal of Applied Toxicology

Volumn 19, Issue 6, 1999, Pages 447-472

  Bantle, J A ^a   Finch, R A ^a   Fort, D J ^a   Stover, E L ^a   Hull, M ^a   Kumsher King, M ^a   Gaudet Hull, A M ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Developmental toxicity; FETAX; Interlaboratory validation; Teratogen; Xenopus

Indexed keywords

TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; MALE; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; TERATOGEN TESTING; VALIDATION PROCESS; XENOPUS;

ACRYLAMIDE; ANIMALS; AROCLOR 1254; ARSENITES; BIOLOGICAL ASSAY; BIOTRANSFORMATION; BORIC ACIDS; BROMATES; DICHLOROACETATE; EMBRYO; ETHYLENE GLYCOL; ETHYLENE GLYCOLS; IODOACETATES; MALE; MICROSOMES, LIVER; PHTHALIC ACIDS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SODIUM COMPOUNDS; TERATOGENS; TRICHLOROACETIC ACID; XENOPUS;

ANIMALIA; ANURA; MAMMALIA;

EID: 0032722273     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199911/12)19:6<447::AID-JAT601>3.0.CO;2-4     Document Type: Article

References (44)